The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
having a favorable IGF ghr phenotype and FOXO lowers your SQ FOXO probably plays a role across the board yeah it's like a transcription factor so it's like this global yeah so is sort of the global homeostasis so that's I think FOXO is risk reducing across the board gh are IGF probably more cancer specific
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.